INTERNATIONAL PATENT: REGENXBIO INC. FILES APPLICATION FOR "MICRODYSTROPHIN GENE THERAPY ADMINISTRATION FOR TREATMENT OF DYSTROPHINOPATHIES"

GENEVA, Jan. 6 -- REGENXBIO INC. (9804 Medical Center DriveRockville, MD 20850) filed a patent application (PCT/US2025/035092) for "MICRODYSTROPHIN GENE THERAPY ADMINISTRATION FOR TREATMENT OF DYSTROPHINOPATHIES" on Jun 24, 2025. With publication no. WO/2026/006341, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DASTGIR, Jahannaz (9804 Medical Center DriveRockville, MD 20850), PHILLIPS, Dawn (9804 Medical Center DriveRockville, MD 20850), WILSON, Catherine (9804 Medical Center DriveRockville, MD 20850), SMITH, Jared, B. ...